Progesterone induces neuroprotection associated with immune/inflammatory modulation in experimental traumatic brain injury

Ziwei Zhou,Yadan Li,Ruilong Peng,Mingming Shi,Weiwei Gao,Ping Lei,Jianning Zhang
DOI: https://doi.org/10.1097/wnr.0000000000002013
2024-04-03
Neuroreport
Abstract:Traumatic brain injury (TBI) is a leading cause of death, disability, and cognitive deficits in adults with trauma [ 1 , 2 ]. The secondary brain injury induced by hyperactive immune/inflammatory reactions is heavily responsible for poor clinical prognosis after TBI. Previously, the brain was considered to be an immune-privileged organ, as the blood-brain barrier (BBB) tightly controls the entry of larger particles, such as cells and proteins, into the central nervous system [ 3 ]. However, recent studies suggest that immune activity can occur in the brain, especially after BBB damage, such as that induced by TBI [ 4 ]. After such damage, peripheral immune cells, including macrophages, neutrophils, and T lymphocytes can invade the whole brain, upon which microglia cells are activated. As a consequence, secondary brain injury occurs, further aggravating brain trauma [ 5 ]. Although researchers have made great progress in understanding the pathophysiological mechanisms, developing new pharmaceutic targets, and optimizing the treatment strategies for TBI, we still face the desperate reality that there are not enough therapeutic avenues that can effectively improve TBI prognosis in the clinical setting.
neurosciences
What problem does this paper attempt to address?